Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > November 2005

« Previous month Next month »

30-Nov-2005

Spray insulin war heats up

30-Nov-2005 - Bentley has accelerated the path to launching its novel intranasal spray insulin, signing a license agreement with India's Biocon to develop and market the product in 85 countries throughout Asia,...

Merck slashes 7,000 jobs and shuts manufacturing facilities

30-Nov-2005 - Merck is to cut 7,000 jobs, close five factories and three research facilities, as the US pharmaceutical company continues to suffer from the devastating repercussions caused by its painkiller Vioxx...

Injectables market opening up to China

30-Nov-2005 - Schott Pharmaceutical Packaging will be the first international manufacturer of primary pharmaceutical glass packaging to establish a production site in China, in a move that will increase supply to Chinese...

Hopax expands fine chemical capacity

30-Nov-2005 - Hopax Fine Chemicals is building a new facility in Kaohsiung, Taiwan, in a move to raise current production capacity by five folds and become one of the top providers for...

Lab-based DNA sequence changer tool developed

30-Nov-2005 - Researchers have developed a new laboratory technique, which allows them to change sequences within a DNA molecule. The tool is set to have positive implications in DNA lab-based medical diagnosis...

Lab tool measures egg quality

30-Nov-2005 - A set of laboratory instruments can measure egg quality within minutes,allowing plant managers to save time on the processing line.

Drug dispensing errors closer to eradication

30-Nov-2005 - An automated prescription verification process is proving a valuable tool for the prevention of drug dispensing errors and is now gaining acceptance within the US pharmacy industry.

29-Nov-2005

SemBioSys reports positive plant produced insulin data

29-Nov-2005 - SemBioSys Genetics has demonstrated bio-equivalence of a plant-produced insulin, which if realised, could become a viable alternative to meet the demand for insulin as the incidence of diabetes increases worldwide.

28-Nov-2005

Alcan acquires rest of Propack

28-Nov-2005 - Alcan has acquired the outstanding minority share of Propack in a deal that further cements the company's standing in the Chinese market. The acquisition forms part of a major restructuring...

Accentus crystallisation system world first

28-Nov-2005 - The world's first commercial-scale continuous sonocrystallisation system promises to revolutionise the way crystals are processed in pharmaceutical manufacturing.

Direct Capital acquires 51pc of NZ Pharmaceuticals

28-Nov-2005 - Private equity firm, Direct Capital has acquired a shareholding of 51 per cent in New Zealand Pharmaceuticals (NZP). The investment by Direct Capital aims to tap into the growing potential...

Degussa gives boost to EU research

28-Nov-2005 - Degussa is offering new award for scientific innovation within Europe - one of the highest-endowed research awards in the world - with prize money of €100,000.

Novel catalyst process to enhance drug making

28-Nov-2005 - Researchers have developed a new catalyst process that offers faster reaction rates, a substantially higher product yield and a cleaner production process than is currently available in the pharmaceutical and...

25-Nov-2005

Isopak provides capsule filling solution for herbal market

25-Nov-2005 - Isopak have launched a new semi automatic capsule-filling machine that is designed to deal with non-lubricated substances intended for clinical trials, and drug or product development work.

Merck's shock CEO departure reverberates around industry

25-Nov-2005 - Merck has announced that its chairman of the executive board, Bernhard Scheuble is to leave the company, by mutual agreement, in a surprise departure considering the company's performance, especially in...

BASF improves tablet strength

25-Nov-2005 - BASF launched its new dry binder excipient at CPhI, aimed at increasing the hardness of pharmaceutical tablets and reducing the manufacturing costs associated with damaged and broken tablets.

24-Nov-2005

Catalyst creates new opportunities

24-Nov-2005 - Degussa have discovered a catalyst that improves the efficiency of reductive carbonylation reactions and will provide greater access to new active pharmaceutical ingredients (APIs).

Scientists discover motion protein promotes drug production

24-Nov-2005 - Researchers have shown how protein synthesis is targeted to certain regions of a cell, a process crucial for the cellular motility, which could form a basis for producing a drug...

Sun system strengthens drug counterfeit defense

24-Nov-2005 - Sun Microsystems have strengthened the fight against drug counterfeiting by launching a unique RFID software package tailored to the specific needs of the pharmaceutical industry.

23-Nov-2005

Rexam enters lucrative US drug packaging market

23-Nov-2005 - Global packaging provider Rexam is expanding its US business, announcing this week that it is set to acquire plastic packaging firm Precise Technology - a move that will expand its...

Patheon dominates contract manufacturing

23-Nov-2005 - Patheon has received the 2005 Contract Manufacturing Company of the Year Award from consultancy firm Frost & Sullivan, in recognition of its customer service and innovative market growth strategies.

Vaccine producers' resources meet pandemic demand.

23-Nov-2005 - The surge in vaccines against influenza has surprised Governments across the world, with the stark admission that demand was unforeseen. Avian flu, which has emerged as a real threat to...

Accentus threat to patented drugs

23-Nov-2005 - New legislation has given UK company Accentus the green light to use its novel predictive crystallisation technology to discover and market variations of patented drugs without infringing the original patent.

GenoID announces breakthrough in HPV testing

23-Nov-2005 - GenoID has announced a breakthrough in human papillomavirus (HPV) testing with the first ever laboratory test kit that uses a real-time polymerase chain reaction (real-time PCR) method to detect all...

Wacker's molecule of choice

23-Nov-2005 - Wacker used CPhI Madrid to unveil its new tailor-made molecules, which combines three technology platforms in one, to offer manufacturers the flexibility to choose the most effective and economical pathway...

22-Nov-2005

Researchers reveal neurochemical protection from Alzheimer's

22-Nov-2005 - Scientists have noted that stimulating brain cell receptors for certain hormone-like chemicals in brain cells can protect them from a compound linked to brain cell death and Alzheimer's disease (AD).

21-Nov-2005

Umicore takes 21 per cent stake in Reaxa

21-Nov-2005 - Avecia spin-off, Reaxa, has announced that Umicore has taken a 21 per cent stake in a move that underlines Reaxa's business strategy in looking at joint R&D, new product development...

In-Pharma focus: Clariant's business strategy.

21-Nov-2005 - In the second part of a special report, In-PharmaTechnologist has taken a closer look at the Pharmaceutical Fine Chemicals Business of Clariant, which made a series of announcements on new...

Declining raw material prices sustains Superfos

21-Nov-2005 - Superfos has reported positive third quarter results after a troubled start to the year. The company attributes the turnaround to declining raw material prices and growth in European business sales.

Parliament agrees on REACH compromise

21-Nov-2005 - A European parliament vote on the REACH chemicals legislation last week struck a balance between health, the environment and industry after months of intense debate.

New Solvias chiral ligand kit launched

21-Nov-2005 - Solvias debuted its new 80-member ligand kit at CPhI 2005, offering manufacturers increased flexibility in active pharmaceutical ingredient (API) development and manufacturing.

18-Nov-2005

Degussa shortens time to API purity

18-Nov-2005 - Degussa used CPhI in Madrid to preview its new flow distributor, which reduces the time it takes manufacturers to remove unwanted transition metals from active pharmaceutical ingredients (APIs), by eliminating...

Outsider prepares to launch diabetes blockbuster

18-Nov-2005 - Generex has escalated manufacturing capabilities to meet expected demand for the first ever commercially available non-injectable insulin product, to be launched in Ecuador at the end of the month.

Lanxess restructuring reflects positive 3Q

18-Nov-2005 - Chemical company Lanxess, release its third quarter results that show restructuring strategy is bearing fruit, with sales up and the reduction of net financial debt that is supported by strong...

In-Pharma focus: Clariant's chemistry.

18-Nov-2005 - The Pharmaceutical Fine Chemicals Business of Clariant took the opportunity to review new developments at the CPhI Expo in Madrid, Spain, making announcements on new investments in facilities in Europe...

Flavorx expands in wide open market

18-Nov-2005 - US company Flavorx will make good tasting medicine a reality when it expands its blockbuster medication flavours into the UK pharmacy market, after a continuous stream of consumer and business...

17-Nov-2005

Vasogen's drug impacts inflammation-signalling pathways

17-Nov-2005 - Vasogen announced preclinical data this week, demonstrating the ability of its lead drug candidate to modulate key signalling pathways associated with inflammation, demonstrating therapeutic potential in a range of neurological...

16-Nov-2005

H&R Wasag 3Q figures bode well for 4Q

16-Nov-2005 - German specialty chemicals group, H&R Wasag, increased its sales and earnings in the third quarter of this year, helped by its in-house refinery operations that allow it to counter the...

Avecia activity at Expo hints at API industry upturn.

16-Nov-2005 - Specialty chemical company Avecia featured prominently at the recent CPhI Expo in Madrid, announcing investments and activity, which hint at the business of custom synthesis of APIs and advanced intermediates...

SAFC provides company update at CPhI Expo

16-Nov-2005 - Sigma-Aldrich Fine Chemicals (SAFC) Biosciences chose the CPhI Expo in Madrid to announce a series of updates concerning company activity. The custom manufacturing group is currently undergoing construction of a...

EU generics in position for take-off

16-Nov-2005 - Catch-up legislation from the EU has swept away the handicap on European generics companies, allowing them to research copycat drugs before patent expiry.

Elkhart Healthcare pharmacies add Bar Code technology

16-Nov-2005 - Elkhart General Healthcare System has purchased Omnicell SafetyPak medication packaging technology to help increase dispensing accuracy and improve patient safety.

15-Nov-2005

TorreyPines initiates first-in-class pain drug trial

15-Nov-2005 - TorreyPines Therapeutics has initiated a phase I clinical trial for its first-in-class compound, which claims to offer a non-opioid, non-vascular approach to the management of severe pain.

New lab images lead to better antibiotic design

15-Nov-2005 - Innovative laboratory technology that produces a sharper picture of the nano-machine that translates genetic program into proteins gives a unique insight into how some types of antibiotics work leading to...

14-Nov-2005

Pall reveals faster vaccine production method for avian flu

14-Nov-2005 - Pall Corporation has revealed a unique approach for speeding vaccine production, which could provide a solution to the potentially huge demand for vaccines by governments and pharmaceutical manufacturers in response...

Pain Therapeutics and King Pharma enter opioid alliance

14-Nov-2005 - Pain Therapeutics and King Pharmaceuticals have entered into an alliance to develop and commercialise Remoxy in an alliance worth at least $400 million (€342 million). The deal positions the abuse-resistant...

Pliva posts 9-month net loss of $34 million

14-Nov-2005 - Pliva released its financial results for the first nine months of 2005, which revealed a net loss of $34 million, as the drug maker tries to recover from its loss-making...

Coremed introduces improved drug-delivery insulin technology

14-Nov-2005 - Coremed has introduced its proprietary drug-delivery platform technology that improves absorption of certain proteins and macromolecules such as insulin within the gastrointestinal tract.

New excipient drives industry search for alternatives

14-Nov-2005 - Last month, In-PharmaTechnologist.com reported on Cargill-Cerestar's plans to unveil a new excipient at CPhI which is developed on the back of a directly compressible excipient platform allowing tablets to be...

11-Nov-2005

Croda presents new high purity excipients

11-Nov-2005 - Croda unveiled its new range of Super Refined PEG and Super Refined Oleic Acid drug delivery excipients, claimed to enhance active pharmaceutical ingredient (API) and formulation stability.

MorphoSys deal produces more ab fragments

11-Nov-2005 - A simpler and more cost-effective way of obtaining high yields of antibody fragments, which are used for research, diagnostic and therapeutic applications may be possible after a deal was agreed...

Strong REACH may halt cancer rise

11-Nov-2005 - Doctors and cancer researchers have pleaded with EU politicians to support a strong REACH chemicals regulation in order to halt an increase in cancer rates, congenital malformations and asthma.

Dr. Reddy's expands into Mexico

11-Nov-2005 - Dr. Reddy's Laboratories (DRL) has signed a definitive agreement to acquire Roche's Mexican API business, in a move to drive the next wave of growth in its custom pharmaceutical services...

New webcam gives Cook competitive edge

11-Nov-2005 - Cook Pharmica will be the first contract manufacturer to offer live webcam services, an innovation that will enable both customers and regulatory agencies to view production as it occurs.

10-Nov-2005

Evotec 3Q continues to show improvement

10-Nov-2005 - German biotech company Evotec OAI boosted its third quarter revenues by 18 per cent to €19 million, despite the difficult operating environment for companies supplying drug discovery technologies, continuing its...

Sanofi Pasteur to license novel vaccine adjuvant

10-Nov-2005 - Sanofi Pasteur has entered into a license and supply agreement with Eisai for the use of their novel adjuvant designed to boost the immune response to a broad range of...

Roche to meet flu vaccine demands

10-Nov-2005 - With the aim of meeting government's needs for pandemic planning, Roche has announced it is on track to produce 300 million Tamiflu treatments annually from 2007, after stepping up its production capacity.

DSM continue to expand in emerging economies

10-Nov-2005 - DSM is expanding its anti-infectives production facilities in India, as part of a global restructuring program to improve profitability and retain DSM's position in the penicillin market.

Ferro develops high-purity parenteral sugars

10-Nov-2005 - Ferro introduced its new high-purity, low-endotoxin sucrose, maltose and trehalose sugars at the recent CPhI in Madrid, designed to improve product quality and broaden the market for injectable protein-based APIs.

Foss launches new MultiVial Analyser

10-Nov-2005 - Foss has introduced the latest in its NIRSystems analyser range, featuring the company's XDS near-infrared (NIR) technology, for improved analytical performance in harsh industrial manufacturing environments.

09-Nov-2005

Lanxess sets up new custom manufacturing company

09-Nov-2005 - Lanxess has said it will spin-off its Fine Chemicals operations into a separate business unit that is expected to become independent as of the second quarter next year.

New study may rock generics drug market

09-Nov-2005 - New findings may have significant implications for the growing generics drugs industry, by challenging previous assumptions that all formulations of the same active pharmaceutical ingredient (API) are therapeutically equivalent.

Fisher Scientific posts increase in 3Q profit

09-Nov-2005 - Fisher Scientific International reported it's third quarter performance for 2005, which revealed profit had more than doubled as a result of improved sales and fewer acquisition related charges.

Steris completes freeze dryer sale with GEA

09-Nov-2005 - The GEA Group has completed an agreement to acquire Steris's freeze dryer (lyophiliser) product line, in a deal that aims to strengthen the group's Process Engineering Division in the Process...

Proditec provides affordable tablet inspection

09-Nov-2005 - Proditec exhibited its new automatic visual tablet inspection system at the recent CPhI, designed to provide the first alternative to manual pharmaceutical tablet inspection for smaller laboratories.

08-Nov-2005

Alzheimer's drug impresses in Phase I

08-Nov-2005 - A Phase I clinical trial, which is investigating the pharmacological activities of a compound for the treatment of Alzheimer's disease, has just been completed with results indicating improved efficacy and...

Industries sign up to cut animal testing

08-Nov-2005 - An affirmation that aims to replace the use of laboratory animals in testing was agreed in Brussels by key industry sectors representing the European chemical, pharmaceutical and biotechnology industries.

04-Nov-2005

MFIC to boost nanomaterials development

04-Nov-2005 - A newly signed research and collaboration agreement between MFIC Corporation and The University of Massachusetts Lowell (UML) will facilitate the development of new applications, processes and products in the growing...

pSivida breaks into Chinese drug market

04-Nov-2005 - pSivida has signed a licensing agreement with Beijing's Med-Pharm, in a move that will facilitate distribution of BrachySil in China - the world's fastest growing market for pharmaceuticals.

Positive DSM 3Q trading despite low growth

04-Nov-2005 - DSM announced that higher margins and lower fixed costs had boosted operating profits by 44 per cent to €220 million in the third quarter, with the performance materials and industrial...

AssurX launches corporate compliance system

04-Nov-2005 - AssurX have launched a software process for document control, which will enable pharmaceutical manufacturing companies to streamline their approach to monitoring safety issues and overall quality control efforts.

eCAP tracking tool relaunched to fight fake drugs

04-Nov-2005 - The world's first and only radio frequency identification (RFID) smart cap, originally designed for drug trial compliance monitoring, is being re-launched as an anti-counterfeiting tool.

03-Nov-2005

Gene discovery could broaden cancer research

03-Nov-2005 - Scientists have admitted that an unexpected genetic phenomenon in prostate cancer has changed conventional thinking over approaches in drug treatment of breast, colon and lung malignancies.

Study shows HDL's parasite immunity qualities

03-Nov-2005 - Scientists have discovered how good cholesterol (HDLs) provide human immunity to certain parasites, which may serve as a platform for the assembly and delivery of two naturally occurring proteins that...

Scientists discover HIV efficacy from frog secretions

03-Nov-2005 - Scientists from the US have discovered that compounds secreted by frog skin could be used as a successful treatment in the fight against HIV infection, which if developed further, could...

02-Nov-2005

Lonza/Solvias partnership flourishes

02-Nov-2005 - Lonza and Solvias have confirmed their long-term collaboration in the development and transfer of asymmetric reactions to an industrial scale.

Demand growing for pre-fillable syringes

02-Nov-2005 - The Parenteral Drug Association (PDA) recently held a conference in Munich to fuel the further development of the growing pre-fillable syringe market.

Millipore launches water purification system

02-Nov-2005 - Millipore has launched a new reverse osmosis (type III) water purification system, designed to meet the needs of laboratories that only require up to 30 L/day of purified tap water.

Flamel's finances flounder after string of setbacks

02-Nov-2005 - Troubled firm Flamel reported a sharp decrease in total third quarter revenues - $3.1 million (€2.6 million), compared to $13.3 million this time last year - resulting in a net loss $11.9 million.

$20 billion in untapped generic drug savings

02-Nov-2005 - US consumers could have saved $20 billion (€16.6 billion) in 2004 and even more could be saved in future years by using more generic drugs, according to a new report by Express Scripts.

« Previous month Next month »